Previous Section
Clinical Trials
21. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer).
- Author
- Classe JM; Rauch P; Rodier JF; Morice P; Stoeckle E; Lasry S; Houvenaeghel G;
- Institution
- Department of Oncological Surgery, Centre R. Gauducheau, Site Hopital nord, Bd. J. Monod, 44805 Saint-Herblain Nantes, France. jm-classe@nantes.fnclcc.fr
- Journal
- Gynecol Oncol. 2006 Sep;102(3):523-9. Epub 2006 Feb 28.
- Abstract URL
- Click here to view abstract
22. Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium.
- Author
- Swisher EM; Swensen RE; Greer B; Tamimi H; Goff BA; Garcia R; Koh WJ;
- Institution
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, 1959 N.E. Pacific St., Box 356460, Seattle, WA 98195-6460, USA. swishere@u.washington.edu
- Journal
- Gynecol Oncol. 2006 Jun;101(3):429-35. Epub 2005 Dec 9.
- Abstract URL
- Click here to view abstract
23. Phase III double-blind randomized trial of radiation therapy for stage IIIb cervical cancer in combination with low- or high-dose Z-100: treatment with immunomodulator, more is not better.
- Author
- Noda K; Ohashi Y; Sugimori H; Ozaki M; Niibe H; Ogita S; Kohno I; Hasegawa K; Kikuchi Y; Takegawa Y; Fujii S; Tanaka K; Ochiai K; Kita M; Fujiwara K;
- Institution
- Kinki University, Japan.
- Journal
- Gynecol Oncol. 2006 Jun;101(3):455-63. Epub 2005 Dec 19.
- Abstract URL
- Click here to view abstract
24. Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.
- Author
- McQuellon RP; Thaler HT; Cella D; Moore DH;
- Institution
- Psychosocial Oncology, Comprehensive Cancer Center of Wake Forest University, Department of Internal Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1082, USA. rmcquell@wfubmc.edu
- Journal
- Gynecol Oncol. 2006 May;101(2):296-304. Epub 2006 Jan 10.
- Abstract URL
- Click here to view abstract
25. A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer.
- Author
- Miglietta L; Franzone P; Centurioni MG; Boni L; Tacchini L; Cosso M; Boccardo F; Ferrarini M; Bruzzone M;
- Institution
- Istituto Nazionale per la Ricerca sul Cancro, Genova, Italia. loredana.miglietta@istge.it
- Journal
- Oncology. 2006;70(1):19-24. Epub 2006 Jan 26.
- Abstract URL
- Click here to view abstract
26. Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer.
- Author
- Kawase S; Okuda T; Ikeda M; Ishihara S; Itoh Y; Yanagawa S; Ishigaki T;
- Institution
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya city, Japan.
- Journal
- Gynecol Oncol. 2006 Sep;102(3):493-9. Epub 2006 Feb 14.
- Abstract URL
- Click here to view abstract
27. Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer.
- Author
- Cai HB; Chen HZ; Yin HH;
- Institution
- Department of Gynecologic Oncology, Zhong Nan Hospital, Wuhan University, China. chb2105@sohu.com
- Journal
- J Obstet Gynaecol Res. 2006 Jun;32(3):315-23.
- Abstract URL
- Click here to view abstract
28. A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128.
- Author
- Gaffney DK; Winter K; Dicker AP; Miller B; Eifel PJ; Ryu J; Avizonis V; Fromm M; Greven K;
- Institution
- Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT 84132, USA. david.gaffney@hci.utah.edu
- Journal
- Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):104-9. Epub 2006 Nov 2.
- Abstract URL
- Click here to view abstract
29. Topotecan in combination with cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer.
- Author
- Brave M; Dagher R; Farrell A; Abraham S; Ramchandani R; Gobburu J; Booth B; Jiang X; Sridhara R; Justice R; Pazdur R;
- Institution
- Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland 20993, USA. michael.brave@fda.hhs.gov
- Journal
- Oncology (Williston Park). 2006 Oct;20(11):1401-4, 1410; discussion 1410-11, 1415-6.
- Abstract URL
- Click here to view abstract
30. AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.
- Author
- Dobrowsky W; Huigol NG; Jayatilake RS; Kizilbash NI; Okkan S; Kagiya VT; Tatsuzaki H;
- Institution
- Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle upon Tyne, UK. werner.dobrowsky@nuth.nhs.uk
- Journal
- Radiother Oncol. 2007 Jan;82(1):24-9. Epub 2006 Dec 11.
- Abstract URL
- Click here to view abstract
